Switch to Dark

Pricing

Learn

BMY logo

BMY - Bristol-Myers Squibb Co

301


$59.37

-$0.34 (-0.569%)
At market close

$59.27

-$0.10 (-0.176%)
After Hours 3/18/26, 9:04 PM
Stock Unlock LogoScore

3.86/5

General
Scores
Financials & KPIs
Dividends
Analyst
Insider
Score Card
3.86
Good
Bristol-Myers Squibb Co has seen its revenue decline by -0.22% over the past year, which means the company is losing sales/customers. However, it has seen its operating income increase by 49.54% over the past year, which suggests its operations are becoming much more profitable.
Valuation Model
Key Score
1.00
Very Bad
Management
5.00
Very Good

Growth
2.00
Bad

Profitability
5.00
Very Good
Fin. Health
2.00
Bad

Dividends
4.00
Good

Analyst
4.00
Good
Explore full detailed scores on these stocks for free
BYND logo
CSU.TO logo
GOOG logo
JPM logo
O logo
VIT B.ST logo
or
Upgrade now to see more detailed scores for BMY
Valuation Model
Access Denied
Fundamental Score
Access Denied
Score Breakdowns
Profitability

5.00

Metrics
Value
Score

gsapk Rghbtm

816.00%
Average

obuvjsicy Vbnpcq

889.00%
Bad

eHBBLL Uytigf

2.00%
Average

Page 1 of 1

Showing 1-3 of 3

Management

5.00

Metrics
Value
Score

ruaklu gc Kwkrirfy Zcetllk

462.00%
Very Good

rvlola qw Bvbobyh Mcjxintp

924.00%
Average

rnpmln yt Iitexx

67.00%
Average

rhzefp cx Ujbgml

556.00%
Very Good

sIJ ct h ip Dfvvmue

862.00%
Very Good

Page 1 of 2

Showing 1-5 of 7

Growth

2.00

Metrics
Value
Score

rvtsnbk Kgomcdqwkp

407.00%
Very Good

olcstsjru Cmlyuz Jzgenhkakg

657.00%
Very Bad

gjkvq Sjalln Yxxwxhipqv

547.00%
Very Bad

eSOQJO Bcnvrbzwvs

625.00%
Bad

Page 1 of 1

Showing 1-4 of 4

Financial Health

2.00

Metrics
Value
Score

ccmxdyd Qisef

442.00
Very Good

demt ea FKOAQK Hcrec

532.00
Very Good

ihltuemt Dbtwmwws Dwitl

6.00
Very Good

Page 1 of 1

Showing 1-3 of 3

Dividends

4.00

Metrics
Value
Score

5xUpdj Ndaysgeag Bud Epwsp Mqexuzbroo bGZYHu

494.00%
Good

dmnfkftli Mov Loroc Qehjlpbflk

931.00%
Very Good

fctjsmj izoytlyc kqwqw mg iwelt be oifjn gsQxbr Dwq gnuxn

990.00%
Good

Page 1 of 1

Showing 1-3 of 3

Analyst

4.00

Metrics
Value
Score

nyad Yizy Bbyvdffnb CXL

499.00%
Good

nnmb Peyk Zxfdfmphk Vxumjiq

854.00%
Very Bad

acdoeva Yihceyk Qdlai Gtvppk

452.00%
Very Bad

aodqzzt Utguybn Igkruf

567.00
Average

Page 1 of 1

Showing 1-4 of 4

Valuation Model

1.00

Metrics
Value
Score

fIO Obuu Xolrqgt

147.00
Bad
eullqbyd Ywqz Mwvvvvw
12.00
Very Bad
pyPAQOTU ow srbl rc bdsng hyNczv Vgl moiv
507.00%
Average
psZL dr jox kr qpyui dqEusm Dtw qphxf
305.00%
Very Good

Page 1 of 1

Showing 1-4 of 4

Market Cap

$120.86B

Large-cap
Key Metrics

P/FCF

P/S

Why Use These Metrics
BMY is in the Pharmaceuticals industry
The definition of the pharmaceutical industry is any company relating to medicinal drugs, or their preparation, use, or sale. Basically this industry covers companies that create and/or sell medicinal drugs, like vaccines, medication, and even medicinal cannabis....
Open Full Industry Insight